© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
June 24, 2022
Kai Zhao, PhD, director of the Nasal Physiology and Therapeutic Center in the Department of Otolaryngology at Ohio State University College of Medicine, discusses his research investigating the persistence of taste and smell loss among patients who have been infected and reinfected with COVID-19.
Stephanie Mason believes that pharmacists should expect their involvement in glycemic management to increase in the near future.
Capecitabine (Xeloda) is indicated for adjuvant colon cancer, metastatic colorectal cancer, and metastatic breast cancer.
Hydrogel Burn Pads provide cooling relief for minor burns and absorbs fluid to prevent infection.
June 23, 2022
Insurers are refusing to cover new, highly effective anti-obesity drugs, but some prescribers are getting around the issue.
Vaxneuvance was approved for an expanded indication by the FDA on June 22, 2022, for active immunization in children 6 weeks of age and older.
Simplifying processes reduces errors in compounding, IV pump programming, and physician order entry.
This month's OTC product news features contact lenses for astigmatism, supplements, and children's probiotics.
But investigators find that individuals who had shingles that spread to the central nervous system had nearly twice the risk of developing mental deterioration, though it is rare.